By analyzing the promoter methylation status of candidate genes in CCA cell lines, Andresen et al. identified DCLK1 as a novel epigenetic biomarker for CCA, demonstrating high sensitivity and specificity (Andresen et al. 2012). Here, DCLK1 is linked to cholangiocarcinoma.